Malignant tumors of the female genitals in Russia: State of the art and problems

A. D Kaprin; V. V Starinskiy; G. V Petrova; O. P Gretsova; L. M Aleksandrova

doi:10.17816/aog35275

V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2014, Vol. 1 ›› Issue (2) : 44 -47. DOI: 10.17816/aog35275

Original study articles

research-article

Malignant tumors of the female genitals in Russia: State of the art and problems

Author information +

History +

PDF

Abstract

Presents analysis of morbidity, 5-year survival, and mortality of patients with malignant tumors of the female genitals, based on the data offederal statistical files recorded at PA. Hertzen Moscow Oncological Institute. Approaches to improvement of the efficiency of cancer control measures and care of the female population of Russia are discussed.

Keywords

malignant tumors / female genitals / morbidity / mortality / survival / early diagnosis

Cite this article

Download citation ▾

A. D Kaprin, V. V Starinskiy, G. V Petrova, O. P Gretsova, L. M Aleksandrova. Malignant tumors of the female genitals in Russia: State of the art and problems. V.F.Snegirev Archives of Obstetrics and Gynecology, 2014, 1(2): 44-47 DOI:10.17816/aog35275

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Выступление министра здравоохранения РФ Вероники Скворцовой на Первом национальном съезде врачей. http://docs.cntd.ru/ document/902373539

[2]	Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2012 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2013.

[3]	Каприн А.Д., Старинский В.В., Петрова Г.М. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2014.

[4]	Harris R.E., Lynch A.T., Guirgis H.A. Familial breast cancer: risk to the contralateral breast. J. Natl Cancer Inst. 1978; 60 (5): 955-60.

[5]	Goodwin P.J. Management of familial breast cancer risk. Breast Cancer Res. Treat. 2000; 62 (1): 19-33.

[6]	Anderson E., Berg J., Black R., Bradshaw N., Campbell J., Cetnarskyj R. et al. Predicting breast cancer risk: implications of a «weak» family history // Fam. Cancer. 2008; 7 (4): 361-6.

[7]	Nathanson K.L., Weber B.L. «Other» breast cancer susceptibility genes: searching for more holy grail // Hum. Mol. Genet. 2001; 7: 715-20.

[8]	Walsh T., Casadei S., Coats K.H., Swisher E., Stray S.M., Higgins J. et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2 and TP53 in families at high risk of breast cancer. J.A.M.A. 2006; 295 (12): 1379-88.